Note 13 - Segment Information

12 Months Ended

Jun. 30, 2019

Notes to Financial Statements

Segment Reporting Disclosure [Text Block]

Note

1

3

.

Segment Information

The basis for presenting segment results generally is consistent with overall Company reporting. The Company reports information about its operating segments in accordance with GAAP which establishes standards for reporting information about a company’s operating segments.

The Company has divided its operations into

three

reportable segments as follows: Contract Manufacturing, Branded Proprietary Products and Other Nutraceutical Businesses. The international sales, concentrated primarily in Europe and Canada, for the fiscal years ended

June 30, 2019

and

2018

were

$6,807

and

$6,474,

respectively.

Financial information relating to the fiscal years ended

June 30, 2019

and

2018

operations by business segment are as follows:

		Sales, Net						Segment
		U.S.		International				Gross				Capital		Total
		Customers		Customers		Total		Profit		Depreciation		Expenditures		Assets
Contract Manufacturing	2019	$	41,817	$	6,625	$	48,442	$	5,780	$	286	$	413	$	17,580
	2018		35,803		6,279		42,082		4,471		232		286		12,200
Branded Proprietary Products	2019		137		22		159		2		-		-		427
	2018		204		48		252		42		4		13		543
Other Nutraceutical Businesses	2019		1,216		160		1,376		440		2		1		1,783
	2018		1,229		147		1,376		475		3		1		1,825
Total Company	2019		43,170		6,807		49,977		6,222		288		414		19,790
	2018		37,236		6,474		43,710		4,988		239		300		14,568